Dermal penetration enhancers and drug delivery systems involving same
AssigneeAcrux DDS Pty Ltd
InventorsBarry Leonard Reed, Timothy Matthias Morgan, Barrie Charles Finnin
Life of this patent
Estimating the term…
Loading patent…
AssigneeAcrux DDS Pty Ltd
InventorsBarry Leonard Reed, Timothy Matthias Morgan, Barrie Charles Finnin
Estimating the term…
A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer; characterised in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer; and (iii) at least one volatile liquid; characterised in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal.
A non-occlusive percutaneous or non-occlusive transdermal drug delivery system which comprises:
Dependencies are inferred from the claim text.